Skip to content
Intelligibberish
  • News
  • Articles
  • Guides
  • Tools
  • About

Tag

#biotech

← All articles

Analysis Apr 4, 2026

Anthropic Pays $400M for a 10-Person Biotech Startup

Anthropic acquired Coefficient Bio — fewer than 10 employees, eight months old — for $400 million in stock. The play: making Claude the default AI for drug discovery.

Analysis Mar 20, 2026

Basecamp Research Launches Trillion Gene Atlas to Design Drugs With AI

Partnering with Anthropic, Ultima Genomics, and PacBio, the startup aims to sequence 100 million species and train AI models that can design therapeutics from a disease prompt.

Analysis Mar 6, 2026

The Race to Put AI-Designed Antibodies Into Clinical Trials

Multiple biotech companies are sprinting to bring the first fully AI-designed antibody drugs to human testing. Here's how they're doing it and what it could mean for medicine.

Analysis Mar 5, 2026

Caltech's Sidewinder Method Achieves 1-in-a-Million DNA Assembly Accuracy

New DNA construction technique improves error rates by 10,000x, enabling practical genome-scale synthesis for medicine and biotech

Analysis Feb 27, 2026

Genome Processing Cost Drops From $100 to Under $1

Ecotone AI's open-source framework makes population-scale DNA analysis economically viable for the first time.

Analysis Feb 25, 2026

AI Agent Teams Are Running Biomedical Research Autonomously

Nature Biotechnology paper describes 'in silico team science' where AI agent collectives handle literature review, hypothesis generation, and data analysis

Analysis Feb 11, 2026

Isomorphic Labs Unveils IsoDDE, a Drug Design Engine That Doubles AlphaFold 3's Accuracy

Google DeepMind spinoff claims its unified AI system can identify hidden binding sites and predict drug interactions faster than physics-based methods

Intelligibberish

Independent analysis and commentary on artificial intelligence.

News Articles Guides Tools About Disclosure Privacy RSS

© 2026 Intelligibberish. Signal, not noise.